Acciones Aoxing Pharmaceutical Company Inc Nyse
Acciones
US03740A1060
Farmacéuticos
Ventas 2015 | 25,48 M 23,88 M | Ventas 2016 | 32,33 M 30,3 M | Capitalización | 49,54 M 46,42 M |
---|---|---|---|---|---|
Resultado Neto 2015 | 5 M 4,69 M | Resultado Neto 2016 | 2 M 1,87 M | VE / Ventas 2015 | 5,77 x |
Deuda neta 2015 | 24,8 M 23,24 M | Deuda neta 2016 | 18,56 M 17,39 M | VE / Ventas 2016 | 2,11 x |
P/E ratio 2015 |
20,1
x | P/E ratio 2016 |
23,2
x | Empleados | - |
Rendimiento 2015 * |
-
| Rendimiento 2016 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/08/23 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/11 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+19,27 % | 43,18 mil M | |
+24,05 % | 23,23 mil M | |
+15,11 % | 14,6 mil M | |
+12,33 % | 13,54 mil M | |
+38,36 % | 11,5 mil M | |
-7,63 % | 6789,83 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+10,21 % | 5310,22 M |